Impact of Variations in Urinary pH on the Pharmacokinetics of LY2140023 and LY404039 in Healthy Subjects.

Trial Profile

Impact of Variations in Urinary pH on the Pharmacokinetics of LY2140023 and LY404039 in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Oct 2011

At a glance

  • Drugs Pomaglumetad methionil (Primary)
  • Indications Psychotic disorders
  • Focus Pharmacokinetics
  • Most Recent Events

    • 11 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 28 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top